Who is this course for?
Healthcare professionals, patient advocates, and others interested in regulated psilocybin access in Canada.
ProfessionalNo New Dates
Health Canada Approves First Special Access Program Requests for Psilocybin
This page summarizes Health Canada’s first known Special Access Program authorization for psilocybin, issued to support treatment for six patients experiencing end-of-life distress. It describes the SAP request process, the clinicians involved, and the supply and legal support used.
Decision Summary
- Best fit
- Healthcare professionals, patient advocates, and others interested in regulated psilocybin access in Canada.
- Format
- Not listed
- Time commitment
- 176 days
- Credential signal
- Not listed
Course Overview
This page covers Health Canada’s first known Special Access Program (SAP) authorization for psilocybin after the Food and Drug Regulations were amended on January 5, 2022 to allow access to psilocybin and other restricted drugs through the SAP. It describes the March 21, 2022 authorization received by Dr. Valorie Masuda for six patients experiencing end-of-life distress, treated with psilocybin and psychotherapy by Roots to Thrive. The article also notes the role of GMP synthetic psilocybin donated by Psygen Labs Inc., access to Apex Labs Ltd.’s investigators’ brochure, and pro bono legal support from R-Group Legal. It is an informational news summary for healthcare professionals, patient advocates, and others interested in regulated psilocybin access in Canada.
Who is this for?
Healthcare professionals, patient advocates, and others interested in regulated psilocybin access in Canada.
About the Provider
TheraPsil is a Canadian grassroots nonprofit advancing compassionate, legal access to psilocybin-assisted psychotherapy through clinician training, patient advocacy, and legal reform, having trained over 700 healthcare professionals since 2019. The organization assists Canadians in navigating Health Canada's Special Access Program, supports patient-rights litigation in Federal Court, and operates the PsilWell community-funded clinical trial exploring psilocybin-assisted therapy for general wellbeing.
View all Therapsil coursesCourse FAQ
What is the format and time commitment?
Time commitment: 176 days.
How much does it cost?
This listing does not have a public price yet. Check the provider website for current tuition, fees, or application-based pricing.
Is this course currently available?
The current listing status is No New Dates. Use the provider website for the latest enrollment status.
Related Courses
View all coursesActiveCertificate
Psilocybin Therapy Courses
By Clerkenwell Health
Shares course skills and categories
Psilocybin therapy courses covering clinical and educational material on psilocybin-assisted psychotherapy, preparation, dosing, and integration. Listings on the page vary by provider and format.
Dates not announced
5 hours
Beginner
Price on request
ActiveCertificate
SoundMind Psychedelic Facilitator Training
By SoundMind
Shares course skills and categories
SoundMind Psychedelic Facilitator Training is an 8-month certificate program for Oregon psilocybin facilitator training. It covers psychedelic-assisted therapy topics, including ketamine, psilocybin, and MDMA in therapeutic settings.
Next cohort: Sep 1, 2026
Delivery: Online + United States
Includes medicine self-experience
12 months
Professional
$10,000
ActiveCertificate
Psilocybin Mushroom Facilitator Training
By Blossom
Shares course skills and categories
A DORA-approved psilocybin mushroom facilitator training program based in Colorado for clinical and wellness practitioners. The program combines online curriculum, live calls, study groups, and in-person experiential training focused on education, ethics, and supervised practicum.
Next cohort: Sep 1, 2026
Source lists: 150 hours
Delivery: Online + Lyons, United States + Fort Collins, United States
Includes medicine self-experience
80 hours
Professional
Price on request